Black Rock Inc. Alkermes Plc. Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ALKS
# of Institutions
375Shares Held
166MCall Options Held
231KPut Options Held
158K-
Vanguard Group Inc Valley Forge, PA18.5MShares$623 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$413 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$297 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$255 Million3.55% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny5.48MShares$185 Million0.25% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.53B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...